Titre : Paralysie

Paralysie : Questions médicales fréquentes

Termes MeSH sélectionnés :

Randomized Controlled Trials as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Paralysie : Questions médicales les plus fréquentes", "headline": "Paralysie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Paralysie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-22", "dateModified": "2025-04-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Paralysie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Manifestations neurologiques", "url": "https://questionsmedicales.fr/mesh/D009461", "about": { "@type": "MedicalCondition", "name": "Manifestations neurologiques", "code": { "@type": "MedicalCode", "code": "D009461", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Paralysie faciale", "alternateName": "Facial Paralysis", "url": "https://questionsmedicales.fr/mesh/D005158", "about": { "@type": "MedicalCondition", "name": "Paralysie faciale", "code": { "@type": "MedicalCode", "code": "D005158", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.214" } } }, { "@type": "MedicalWebPage", "name": "Gastroparésie", "alternateName": "Gastroparesis", "url": "https://questionsmedicales.fr/mesh/D018589", "about": { "@type": "MedicalCondition", "name": "Gastroparésie", "code": { "@type": "MedicalCode", "code": "D018589", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.263" } } }, { "@type": "MedicalWebPage", "name": "Hémiplégie", "alternateName": "Hemiplegia", "url": "https://questionsmedicales.fr/mesh/D006429", "about": { "@type": "MedicalCondition", "name": "Hémiplégie", "code": { "@type": "MedicalCode", "code": "D006429", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.312" } } }, { "@type": "MedicalWebPage", "name": "Ophtalmoplégie", "alternateName": "Ophthalmoplegia", "url": "https://questionsmedicales.fr/mesh/D009886", "about": { "@type": "MedicalCondition", "name": "Ophtalmoplégie", "code": { "@type": "MedicalCode", "code": "D009886", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.447" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ophtalmoplégie externe progressive", "alternateName": "Ophthalmoplegia, Chronic Progressive External", "url": "https://questionsmedicales.fr/mesh/D017246", "about": { "@type": "MedicalCondition", "name": "Ophtalmoplégie externe progressive", "code": { "@type": "MedicalCode", "code": "D017246", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.447.511" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Syndrome de Kearns-Sayre", "alternateName": "Kearns-Sayre Syndrome", "url": "https://questionsmedicales.fr/mesh/D007625", "about": { "@type": "MedicalCondition", "name": "Syndrome de Kearns-Sayre", "code": { "@type": "MedicalCode", "code": "D007625", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.447.511.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Syndrome de Kearns-Sayre", "alternateName": "Kearns-Sayre Syndrome", "url": "https://questionsmedicales.fr/mesh/D007625", "about": { "@type": "MedicalCondition", "name": "Syndrome de Kearns-Sayre", "code": { "@type": "MedicalCode", "code": "D007625", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.447.511.500" } } }, { "@type": "MedicalWebPage", "name": "Migraine ophtalmoplégique", "alternateName": "Ophthalmoplegic Migraine", "url": "https://questionsmedicales.fr/mesh/D060486", "about": { "@type": "MedicalCondition", "name": "Migraine ophtalmoplégique", "code": { "@type": "MedicalCode", "code": "D060486", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.447.600" } } }, { "@type": "MedicalWebPage", "name": "Paralysie supranucléaire progressive", "alternateName": "Supranuclear Palsy, Progressive", "url": "https://questionsmedicales.fr/mesh/D013494", "about": { "@type": "MedicalCondition", "name": "Paralysie supranucléaire progressive", "code": { "@type": "MedicalCode", "code": "D013494", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.447.690" } } } ] }, { "@type": "MedicalWebPage", "name": "Paraplégie", "alternateName": "Paraplegia", "url": "https://questionsmedicales.fr/mesh/D010264", "about": { "@type": "MedicalCondition", "name": "Paraplégie", "code": { "@type": "MedicalCode", "code": "D010264", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.637" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Syndrome de Brown-Séquard", "alternateName": "Brown-Sequard Syndrome", "url": "https://questionsmedicales.fr/mesh/D018437", "about": { "@type": "MedicalCondition", "name": "Syndrome de Brown-Séquard", "code": { "@type": "MedicalCode", "code": "D018437", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.637.300" } } } ] }, { "@type": "MedicalWebPage", "name": "Paralysie pseudobulbaire", "alternateName": "Pseudobulbar Palsy", "url": "https://questionsmedicales.fr/mesh/D020828", "about": { "@type": "MedicalCondition", "name": "Paralysie pseudobulbaire", "code": { "@type": "MedicalCode", "code": "D020828", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.711" } } }, { "@type": "MedicalWebPage", "name": "Tétraplégie", "alternateName": "Quadriplegia", "url": "https://questionsmedicales.fr/mesh/D011782", "about": { "@type": "MedicalCondition", "name": "Tétraplégie", "code": { "@type": "MedicalCode", "code": "D011782", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.786" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Syndrome de déefférentation motrice", "alternateName": "Locked-In Syndrome", "url": "https://questionsmedicales.fr/mesh/D000080422", "about": { "@type": "MedicalCondition", "name": "Syndrome de déefférentation motrice", "code": { "@type": "MedicalCode", "code": "D000080422", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.786.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Paralysie des muscles respiratoires", "alternateName": "Respiratory Paralysis", "url": "https://questionsmedicales.fr/mesh/D012133", "about": { "@type": "MedicalCondition", "name": "Paralysie des muscles respiratoires", "code": { "@type": "MedicalCode", "code": "D012133", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.812" } } }, { "@type": "MedicalWebPage", "name": "Paralysie des cordes vocales", "alternateName": "Vocal Cord Paralysis", "url": "https://questionsmedicales.fr/mesh/D014826", "about": { "@type": "MedicalCondition", "name": "Paralysie des cordes vocales", "code": { "@type": "MedicalCode", "code": "D014826", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.592.636.943" } } } ], "about": { "@type": "MedicalCondition", "name": "Paralysie", "alternateName": "Paralysis", "code": { "@type": "MedicalCode", "code": "D010243", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jordan W Squair", "url": "https://questionsmedicales.fr/author/Jordan%20W%20Squair", "affiliation": { "@type": "Organization", "name": "Defitech Center for Interventional Neurotherapies (NeuroRestore), Lausanne University Hospital (CHUV)-University of Lausanne (UNIL)-École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland." } }, { "@type": "Person", "name": "Sa Yang", "url": "https://questionsmedicales.fr/author/Sa%20Yang", "affiliation": { "@type": "Organization", "name": "Institute of Apicultural Research, Chinese Academy of Agricultural Sciences, Beijing 100093, China." } }, { "@type": "Person", "name": "Hongxia Zhao", "url": "https://questionsmedicales.fr/author/Hongxia%20Zhao", "affiliation": { "@type": "Organization", "name": "Guangdong Key Laboratory of Animal Conservation and Resource Utilization, Guangdong Public Laboratory of Wild Animal Conservation and Utilization, Guangdong Institute of Applied Biological Resources, Guangzhou 510260, China." } }, { "@type": "Person", "name": "Shuai Deng", "url": "https://questionsmedicales.fr/author/Shuai%20Deng", "affiliation": { "@type": "Organization", "name": "Institute of Apicultural Research, Chinese Academy of Agricultural Sciences, Beijing 100093, China." } }, { "@type": "Person", "name": "Xinling Wang", "url": "https://questionsmedicales.fr/author/Xinling%20Wang", "affiliation": { "@type": "Organization", "name": "Institute of Apicultural Research, Chinese Academy of Agricultural Sciences, Beijing 100093, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Estimating survival scenarios in advanced or metastatic gastric and oesophageal adenocarcinoma: a systematic review of randomized-controlled trials.", "datePublished": "2024-07-13", "url": "https://questionsmedicales.fr/article/38961804", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/03007995.2024.2376129" } }, { "@type": "ScholarlyArticle", "name": "Usability and Preliminary Efficacy of an Adaptive Supportive Care System for Patients With Cancer: Pilot Randomized Controlled Trial.", "datePublished": "2024-07-10", "url": "https://questionsmedicales.fr/article/38986134", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2196/49703" } }, { "@type": "ScholarlyArticle", "name": "Effects of Preoperative Oral Carbohydrates on Recovery After Laparoscopic Cholecystectomy: A Meta-analysis of Randomized Controlled Trials.", "datePublished": "2024-07-08", "url": "https://questionsmedicales.fr/article/38980237", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jopan.2024.03.007" } }, { "@type": "ScholarlyArticle", "name": "Great expectations: A multisite, randomized controlled open-label trial of a novel patient expectations communication tool.", "datePublished": "2024-07-06", "url": "https://questionsmedicales.fr/article/38975016", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/emp2.13229" } }, { "@type": "ScholarlyArticle", "name": "Azithromycin Dosing and Preterm premature rupture of membranes Treatment (ADAPT): A randomized controlled Phase I trial.", "datePublished": "2024-07-06", "url": "https://questionsmedicales.fr/article/38977063", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajogmf.2024.101423" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Manifestations neurologiques", "item": "https://questionsmedicales.fr/mesh/D009461" }, { "@type": "ListItem", "position": 5, "name": "Paralysie", "item": "https://questionsmedicales.fr/mesh/D010243" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Paralysie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Paralysie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Paralysie", "description": "Comment diagnostique-t-on la paralysie ?\nQuels tests sont utilisés pour évaluer la paralysie ?\nLa paralysie peut-elle être temporaire ?\nQuels signes indiquent une paralysie ?\nLa paralysie est-elle toujours complète ?", "url": "https://questionsmedicales.fr/mesh/D010243?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=998#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Paralysie", "description": "Quels sont les symptômes courants de la paralysie ?\nLa paralysie affecte-t-elle la parole ?\nPeut-on ressentir des douleurs avec la paralysie ?\nLa paralysie peut-elle causer des problèmes respiratoires ?\nY a-t-il des symptômes associés à la paralysie faciale ?", "url": "https://questionsmedicales.fr/mesh/D010243?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=998#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Paralysie", "description": "Comment prévenir la paralysie après un AVC ?\nPeut-on prévenir la paralysie due à des blessures ?\nLes vaccinations peuvent-elles prévenir certaines paralysies ?\nL'exercice régulier aide-t-il à prévenir la paralysie ?\nUne alimentation saine peut-elle prévenir la paralysie ?", "url": "https://questionsmedicales.fr/mesh/D010243?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=998#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Paralysie", "description": "Quels traitements sont disponibles pour la paralysie ?\nLa chirurgie peut-elle aider en cas de paralysie ?\nLes médicaments peuvent-ils traiter la paralysie ?\nLa thérapie occupationnelle est-elle utile ?\nLes dispositifs d'assistance sont-ils recommandés ?", "url": "https://questionsmedicales.fr/mesh/D010243?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=998#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Paralysie", "description": "Quelles complications peuvent survenir avec la paralysie ?\nLa paralysie peut-elle entraîner des problèmes psychologiques ?\nLes complications cardiovasculaires sont-elles fréquentes ?\nLa paralysie peut-elle affecter la nutrition ?\nY a-t-il des risques d'isolement social ?", "url": "https://questionsmedicales.fr/mesh/D010243?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=998#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Paralysie", "description": "Quels sont les principaux facteurs de risque de paralysie ?\nLe tabagisme augmente-t-il le risque de paralysie ?\nL'âge est-il un facteur de risque pour la paralysie ?\nLe stress peut-il contribuer à la paralysie ?\nLes maladies auto-immunes sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D010243?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=998#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on la paralysie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et des tests d'imagerie comme l'IRM." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la paralysie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des électromyogrammes et des tests de conduction nerveuse sont souvent réalisés." } }, { "@type": "Question", "name": "La paralysie peut-elle être temporaire ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines paralysies, comme celles dues à un AVC, peuvent être temporaires." } }, { "@type": "Question", "name": "Quels signes indiquent une paralysie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des signes incluent une faiblesse musculaire, une perte de sensation ou des réflexes diminués." } }, { "@type": "Question", "name": "La paralysie est-elle toujours complète ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Non, elle peut être partielle, affectant seulement certains muscles ou groupes musculaires." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de la paralysie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent une faiblesse, une perte de mouvement et des troubles de la sensation." } }, { "@type": "Question", "name": "La paralysie affecte-t-elle la parole ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la paralysie peut affecter la parole si les muscles de la bouche sont touchés." } }, { "@type": "Question", "name": "Peut-on ressentir des douleurs avec la paralysie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs neuropathiques peuvent survenir en raison de lésions nerveuses." } }, { "@type": "Question", "name": "La paralysie peut-elle causer des problèmes respiratoires ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, si les muscles respiratoires sont affectés, cela peut entraîner des difficultés respiratoires." } }, { "@type": "Question", "name": "Y a-t-il des symptômes associés à la paralysie faciale ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme l'affaissement d'un côté du visage et des difficultés à fermer l'œil peuvent apparaître." } }, { "@type": "Question", "name": "Comment prévenir la paralysie après un AVC ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La réhabilitation précoce et le contrôle des facteurs de risque comme l'hypertension sont essentiels." } }, { "@type": "Question", "name": "Peut-on prévenir la paralysie due à des blessures ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des mesures de sécurité comme le port de casques peuvent réduire les risques de blessures." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles prévenir certaines paralysies ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des vaccins comme celui contre la poliomyélite peuvent prévenir des formes de paralysie." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il à prévenir la paralysie ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut améliorer la santé cardiovasculaire et réduire les risques d'AVC." } }, { "@type": "Question", "name": "Une alimentation saine peut-elle prévenir la paralysie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée aide à maintenir une bonne santé nerveuse et cardiovasculaire." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour la paralysie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la rééducation, la physiothérapie et parfois des médicaments." } }, { "@type": "Question", "name": "La chirurgie peut-elle aider en cas de paralysie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la chirurgie peut être nécessaire pour réparer des nerfs ou des structures endommagées." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils traiter la paralysie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments anti-inflammatoires ou des relaxants musculaires peuvent être prescrits." } }, { "@type": "Question", "name": "La thérapie occupationnelle est-elle utile ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide les patients à retrouver leur autonomie dans les activités quotidiennes." } }, { "@type": "Question", "name": "Les dispositifs d'assistance sont-ils recommandés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dispositifs comme des fauteuils roulants ou des orthèses peuvent améliorer la mobilité." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la paralysie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des infections, des escarres et des problèmes respiratoires." } }, { "@type": "Question", "name": "La paralysie peut-elle entraîner des problèmes psychologiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles comme la dépression et l'anxiété peuvent survenir chez les patients paralysés." } }, { "@type": "Question", "name": "Les complications cardiovasculaires sont-elles fréquentes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'immobilité prolongée peut augmenter le risque de thrombose et d'embolie." } }, { "@type": "Question", "name": "La paralysie peut-elle affecter la nutrition ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des difficultés à avaler peuvent entraîner des problèmes nutritionnels chez certains patients." } }, { "@type": "Question", "name": "Y a-t-il des risques d'isolement social ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la paralysie peut limiter les interactions sociales, entraînant un isolement." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque de paralysie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'hypertension, le diabète, et les antécédents familiaux d'AVC." } }, { "@type": "Question", "name": "Le tabagisme augmente-t-il le risque de paralysie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est un facteur de risque majeur pour les AVC et les maladies cardiovasculaires." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour la paralysie ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de paralysie augmente avec l'âge, surtout après 65 ans." } }, { "@type": "Question", "name": "Le stress peut-il contribuer à la paralysie ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la santé cardiovasculaire et augmenter le risque d'AVC." } }, { "@type": "Question", "name": "Les maladies auto-immunes sont-elles un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies auto-immunes peuvent endommager les nerfs et entraîner une paralysie." } } ] } ] }

Sources (10000 au total)

Estimating survival scenarios in advanced or metastatic gastric and oesophageal adenocarcinoma: a systematic review of randomized-controlled trials.

We aimed to summarize survival data from RCTs in patients with GO adenocarcinoma; estimate and explain worst-, typical-, and best-case-scenarios of survival time; and determine if simple multiples of ... We systematically searched RCTs of systemic therapies for GO adenocarcinoma published 2000-2022. The following key percentiles were extracted from overall survival curves: 90th (worst-case), 75th (low... We identified 44 trials (22,447 participants). For first line chemotherapy and immunotherapy combined (CI) trials (... We provide realistic, evidence-based prognostic information as scenarios for survival time which can inform clinical decision-making. Simple multiples of the mOS accurately estimated the percentiles f...

Usability and Preliminary Efficacy of an Adaptive Supportive Care System for Patients With Cancer: Pilot Randomized Controlled Trial.

Using an iterative user-centered design process, our team developed a patient-centered adaptive supportive care system, PatientCareAnywhere, that provides comprehensive biopsychosocial screening and s... This study aims to assess the usability of the new web-based PatientCareAnywhere system and examine the preliminary efficacy of PatientCareAnywhere to improve patient-reported outcomes compared with u... For phase 1, usability testing participants included patients with cancer (n=4) and caregivers (n=7) who evaluated the software prototype and provided qualitative (eg, interviews) and quantitative (eg... Participants were highly satisfied with the prototype and reported above-average acceptable usability, with a mean System Usability Scale score of 84.09 (SD 10.02). Qualitative data supported the over... Overall, PatientCareAnywhere represents a user-friendly, functional, and acceptable supportive care intervention with preliminary efficacy to improve HRQOL among patients diagnosed with cancer. Future... ClinicalTrials.gov NCT02408406; https://clinicaltrials.gov/study/NCT02408406....

Effects of Preoperative Oral Carbohydrates on Recovery After Laparoscopic Cholecystectomy: A Meta-analysis of Randomized Controlled Trials.

The objective of this meta-analysis was to evaluate the efficacy of administering preoperative oral carbohydrates (CHO) compared to a control treatment in improving postoperative recovery outcomes for... A meta-analysis of randomized controlled trials.... Through systematic searches in PubMed, Embase, and the Cochrane Library, randomized controlled trials focusing on preoperative oral carbohydrates for patients undergoing LC were collected. Data analys... The meta-analysis incorporated 19 randomized studies, with a total of 1,568 participants. Meta-analysis results indicated that patients receiving CHO reported notably lower postoperative pain compared... Preoperative oral carbohydrates may alleviate hunger and pain, and attenuate postoperative insulin resistance more effectively than either overnight fasting or placebo in patients undergoing LC....

Great expectations: A multisite, randomized controlled open-label trial of a novel patient expectations communication tool.

In emergency medicine (EM), discerning patient expectations to inform patient-centered care poses unique challenges. We devised a novel questionnaire to facilitate clinicians' understanding of patient... We conducted a multisite, randomized controlled trial. A brief questionnaire soliciting patient expectations was developed through feedback from clinicians and patients. At the beginning of their visi... Among the 308 participants, 141 intervention and 123 control exit surveys were collected. In the primary analysis, the intervention group had 2.1 times greater odds of strongly agreeing that their cli... While more patients reported that their expectations were addressed when the novel tool was used, no significant difference was found for conventional satisfaction measures. Future studies may examine...

Azithromycin Dosing and Preterm premature rupture of membranes Treatment (ADAPT): A randomized controlled Phase I trial.

Seven days of antibiotics are recommended in the setting of preterm premature rupture of membranes (PPROM) to promote latency. Azithromycin has generally replaced a seven-day course of erythromycin in... We aim to compare the pharmacokinetics of one-time vs daily dosing of azithromycin in the setting of preterm pre-labor rupture of membranes (PPROM) STUDY DESIGN: This is a randomized clinical trial of... The study was halted after N=6 enrolled due to lagging enrollment, with 3 in each group. The mean gestational age of enrollment was 27.1±1.7weeks in the 1g group and 31.0±1.4 weeks in the 500mg daily ... 500mg daily dosing of azithromycin maintains higher amniotic fluid concentrations, and more consistently greater than common MICs, over eight days compared to 1g once in the setting of PPROM....

Comparing Prefabricated and 3D Printed Foot Orthoses for the Management of Flat Foot Condition: A Randomized Controlled Trial.

To investigate the short-term effects of 3D-printed and prefabricated foot orthoses on the management of flat feet.... In this single-blinded study, 63 patients with flat feet were enrolled via convenience sampling. They were randomly assigned to the control and experimental groups, receiving prefabricated and customi... VAS scores at week 0 for the two groups were not statistically significant (p > 0.05). At week 4, the VAS scores of the experimental group reduced significantly (p < 0.001), whereas the VAS scores of ... Customized 3D-printed orthoses effectively reduced pain and enhanced patient satisfaction with comfort and effectiveness in 4 weeks....

Assessing the efficacy of manual reduction and novel traction techniques for distal radius fractures: A randomized controlled trial.

One of the leading reasons that patients, particularly older persons, are brought to the orthopedic emergency room is a fracture at the end of the radius. In this study, a new traction method for dist... The census method was used in this clinical trial to study 45 patients (46 hands) who were referred to Hamedan Besat Hospital in 2021. Patients were randomly assigned to two groups. The manual reducti... The following results were observed in the new and manual groups in the sixth week after surgery: average volar tilt: 4.19 ± 3.79 and 4.08 ± 3.88 (... The new reduction procedure with hardware in patients with distal radius fractures showed the same effect as the traditional method based on pressure and traction by the assistant and doctor in terms ...

Effects of a Patient Portal Intervention to Address Diabetes Care Gaps: Protocol for a Pragmatic Randomized Controlled Trial.

Despite the potential to significantly reduce complications, many patients do not consistently receive diabetes preventive care. Our research team recently applied user-centered design sprint methodol... This study aims to evaluate the effect of our novel diabetes care gap intervention on completion of selected evidence-based diabetes preventive care services and secondary outcomes.... We are conducting a pragmatic randomized controlled trial of the effect of the intervention on diabetes care gaps. Adult patients with diabetes mellitus (DM) are recruited from primary care clinics af... This study is ongoing. Recruitment was closed in February 2022; a total of 433 patients were randomized. Of those randomized, most (n=288, 66.5%) were non-Hispanic White, 33.5% (n=145) were racial or ... The study directly tests the hypothesis that a patient portal intervention-alerting patients about selected diabetes care gaps, fostering understanding of their significance, and allowing patients to ... ClinicalTrials.gov NCT04894903; https://classic.clinicaltrials.gov/ct2/show/NCT04894903.... DERR1-10.2196/56123....

Randomized Controlled Trial of Enhanced Recovery After Surgery Protocols in Live Kidney Donors: ERASKT Study.

Enhanced recovery after surgery (ERAS) pathways represent a comprehensive approach to optimizing perioperative management and reducing hospital stay and cost. In living donor kidney transplantation, k... In this randomized controlled trial, living kidney transplantation donors were assigned to either the ERAS or control group. The ERAS group patients received 15 preoperative, 17 intraoperative, 19 pos... There were no significant differences in demographics between the 2 groups. The ERAS group had a statistically significant reduction in total postoperative opioid consumption calculated in intravenous... The ERAS group experienced superior postoperative analgesia and a shorter length of hospital stay compared with controls....

Investigation of Inspiratory Muscle Training Efficiency Before Bronchoscopic Lung Volume Reduction: A Randomized Controlled Trial.

Pulmonary rehabilitation (PR) is recommended prior to bronchoscopic lung volume reduction (BLVR) procedures to optimize patient outcomes. However, there's a lack of clear guidance on PR content. The a... Sixty-four patients were randomly assigned to either the PR Group (PRGr) or the PR with IMT group (IMTGr). Both groups underwent an 8-week standard PR program, including breathing exercises, muscle st... Our study found no significant difference in exercise capacity improvement between IMTGr and PRGr. However, IMTGr showed significant improvement in MIP compared to PRGr. Both groups experienced improv... Adding IMT to PR did not show a significant difference between groups among BLVR-eligible patients. However, improved respiratory muscle strength may have positive clinical implications. Further resea...